Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Iacobucci G. HIV: dolutegravir should be preferred treatment option in all populations, says WHO. BMJ 2019;366:l4831.
PMID: 31337663


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016